Position
Chief Medical Officer
Company
ALX Oncology
South San FranciscoBiotechnologyHealth CareMedicalTherapeuticsDescription
ALX Oncology has appointed Dr Barbara Klencke as Interim Chief Medical Officer following the resignation of Dr. Alan Sandler from the role. Dr Klencke, who has extensive experience in oncology drug development, will transition from her current position on the Board of Directors to lead the company’s medical strategy.
Quick answer
ALX Oncology Appoints Barbara Klencke as Interim Chief Medical Officer (September 12, 2025). ALX Oncology is based in South San Francisco, California, United States.
- Who is the new Chief Medical Officer at ALX Oncology?
- ALX Oncology named Barbara Klencke Chief Medical Officer, announced September 12, 2025.
- What did ALX Oncology announce on September 12, 2025?
- ALX Oncology has appointed Dr Barbara Klencke as Interim Chief Medical Officer following the resignation of Dr. Alan Sandler from the role. Dr Klencke, who has extensive experience in oncology drug development, will transition from her current position on the Board of Directors to lead the company’s medical strategy.
- What does ALX Oncology do?
- ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives.
- Where is ALX Oncology based?
- ALX Oncology is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Vyome Holdings (September 9, 2025), Genentech (September 17, 2025), DeepQure (September 3, 2025) and Parexel (August 21, 2025) also announced leadership changes within 45 days of ALX Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Vyome Holdings Appoints Dr. Richard Fahrner as Chief Technology Officer (September 9, 2025)
- Genentech Appoints Zoë Harris Lazarre as Chief Marketing Officer (September 17, 2025)
- DeepQure Appoints Jason G. Jones as Global Vice President of Clinical & Regulatory Affairs (September 3, 2025)
- Parexel Appoints Jim Anthony as Chief Commercial Officer and President (August 21, 2025)
- Diakonos Oncology Appoints Donna Rill as Chief Technology Officer (August 12, 2025)
- Hansa Biopharma Appoints Brian Gorman as Chief Legal Officer and Sandra Frithiof as Chief Human Resources Officer (July 29, 2025)
Who to call at ALX Oncology, and when
A new leader at ALX Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ALX Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ALX Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ALX Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ALX Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ALX Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.